| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $55.4M | +41.0% |
| SG&A Expense | $19.2M | +29.6% |
| Operating Income | -$74.7M | -37.9% |
| Net Income | -$67.7M | -27.7% |
| EPS (Basic) | -$1.65 | +8.8% |
| EPS (Diluted) | -$1.65 | +8.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $193.2M | +136.8% |
| Short-term Investments | $48.0M | +92.5% |
| Current Assets | $244.5M | +124.6% |
| Total Assets | $253.7M | +116.9% |
| Current Liabilities | $16.0M | +68.6% |
| Total Liabilities | $17.5M | +40.2% |
| Stockholders' Equity | $236.2M | +126.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.5M | -15.5% |
| Capital Expenditures | $687K | -72.0% |
| Investing Cash Flow | -$22.5M | +17.5% |
| Financing Cash Flow | $187.6M | +468.9% |
| Free Cash Flow | -$54.2M | -11.1% |